Molecular targeting of VHL gene pathway in clear cell kidney cancer
- PMID: 12853837
- DOI: 10.1097/01.ju.0000077210.05543.ae
Molecular targeting of VHL gene pathway in clear cell kidney cancer
Comment on
-
Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.J Urol. 2003 Aug;170(2 Pt 1):588-92. doi: 10.1097/01.ju.0000074870.54671.98. J Urol. 2003. PMID: 12853836
Similar articles
-
Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.J Urol. 2003 Aug;170(2 Pt 1):588-92. doi: 10.1097/01.ju.0000074870.54671.98. J Urol. 2003. PMID: 12853836
-
Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.Oncogene. 2000 Nov 16;19(48):5435-43. doi: 10.1038/sj.onc.1203938. Oncogene. 2000. PMID: 11114720
-
Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.Cancer Res. 2003 May 15;63(10):2675-80. Cancer Res. 2003. PMID: 12750296
-
Von Hippel-Lindau disease.Microsc Res Tech. 2003 Feb 1;60(2):159-64. doi: 10.1002/jemt.10253. Microsc Res Tech. 2003. PMID: 12539169 Review.
-
Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene.Kidney Int. 1997 Feb;51(2):575-8. doi: 10.1038/ki.1997.82. Kidney Int. 1997. PMID: 9027742 Review.
Cited by
-
Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients.Tumour Biol. 2014 Oct;35(10):9839-45. doi: 10.1007/s13277-014-2194-4. Epub 2014 Jul 3. Tumour Biol. 2014. PMID: 24989926
-
Von Hippel-Lindau Syndrome: Multi-Organ Involvement Highlighting Its Diverse Clinical Spectrum in Two Adult Cases.Cureus. 2020 Jul 26;12(7):e9402. doi: 10.7759/cureus.9402. Cureus. 2020. PMID: 32864232 Free PMC article.
-
A tumor-specific gene therapy strategy targeting dysregulation of the VHL/HIF pathway in renal cell carcinomas.Cancer Sci. 2005 May;96(5):288-94. doi: 10.1111/j.1349-7006.2005.00044.x. Cancer Sci. 2005. PMID: 15904470 Free PMC article.
-
THSD7A expression: a novel immunohistochemical determinant in predicting overall survival of metastatic renal cell carcinoma treated with targeted therapy.Ir J Med Sci. 2022 Aug;191(4):1561-1567. doi: 10.1007/s11845-021-02759-0. Epub 2021 Sep 1. Ir J Med Sci. 2022. PMID: 34472040
-
Aerobic glycolysis: a novel target in kidney cancer.Expert Rev Anticancer Ther. 2013 Jun;13(6):711-9. doi: 10.1586/era.13.57. Expert Rev Anticancer Ther. 2013. PMID: 23773105 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical